Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Vladan Vucinic, MD, Sabine Leiblein, PhD, Kristina Schakols, MD, Claudia Nehring, MD, Yvonne Remane, PhD, Madlen Jentzsch, MD, Sebastian Schwind, MD, Wolfram Pönisch, MD, Runa Stiegler, MD, Constanze Kliem, MD, Michael Cross, PhD, Dietger Niederwieser, MD

Blood (2018) 132 (Supplement 1): 2064.

https://doi.org/10.1182/blood-2018-99-118531

Published: 2018

Journal Articles

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Madlen Jentzsch, MD, Luba Schuhmann, Marius Bill, MDPhD, Sabine Leiblein, PhD, Ulrike Bergmann, Martina Pless, Karoline Schubert, Laura Katharina Schmalbrock, MD, Juliane Grimm, Maria Knyrim, Wolfram Poenisch, MD, Georg-Nikolaus Franke, MD, Vladan Vucinic, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 2573.

https://doi.org/10.1182/blood.V126.23.2573.2573

Published: 2015

Journal Articles

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Madlen Jentzsch, MD, Elena Ruschpler, Sabine Leiblein, PhD, Yvonne Remane, Jan-Phillip Stümpel, MD, Georg-Nikolaus Franke, MD, Simone Heyn, MD, Nadja Jaekel, MD, Susann Schulze, MD, Song-Yau Wang, MD, Wolfram Poenisch, MD, Claudia Nehring, MD, Sebastian Schwind, MD, Dietger Niederwieser, MD, Vladan Vucinic, MD

Blood (2015) 126 (23): 5439.

https://doi.org/10.1182/blood.V126.23.5439.5439

Published: 2015

Journal Articles

Mobilization of Allogeneic Peripheral Blood Stem Cells in Family Donors with Single-Dose Pegfilgrastim.

Vladan Vucinic, Nadezda Basara, Runa Stiegler, Kristina Bartsch, Constanze Kliem, Sabine Leiblein, PhD, Dietger Niederwieser

Blood (2009) 114 (22): 2148.

https://doi.org/10.1182/blood.V114.22.2148.2148

Published: 2009

Journal Articles

Elevated Serum Hepcidin in Patients with AML Prior to and After Allogeneic Hematopoietic Cell Transplantation Does Not Correlate with Transfusional Body Iron, HFE Genotype or Graft Versus Host Disease and May Protect From Excessive Parenchymal Iron Loading.

Ann-Kathrin Eisfeld, Mark Westerman, PhD, Rainer Krahl, Sabine Leiblein, PhD, Uwe Gerd Liebert, Marianne Hehme, Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD

Blood (2009) 114 (22): 4047.

https://doi.org/10.1182/blood.V114.22.4047.4047

Published: 2009

Journal Articles

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, PhD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2007) 110 (11): 1654.

https://doi.org/10.1182/blood.V110.11.1654.1654

Published: 2007

Journal Articles

Donor CD34+ Cell Chimerism at Day 28 and Chronic Graft-Versus-Host Disease (GvHD) but Not High-Risk Cytogenetics Influence Outcome of Allogeneic Hematopoetic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, MD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2006) 108 (11): 547.

https://doi.org/10.1182/blood.V108.11.547.547

Published: 2006

Journal Articles

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma after Conventional Chemotherapy: Final Results of a Phase I Study.

Wolfram Poenisch, MD, Marta Rozanski, Sabine Leiblein, PhD, Hartmut Goldschmidt, MD, Franz A. Hoffmann, MD, Thomas Boldt, MD, Robert Rohrberg, MD, Elke Schwalbe, MD, Jens Uhlig, MD, Dietger Niederwieser, MD

Blood (2005) 106 (11): 5154.

https://doi.org/10.1182/blood.V106.11.5154.5154

Published: 2005

Journal Articles

Comparable Distribution of Minimal Residual Diesease between CD34 Positive Hematopoietic Progenitors, CD34 Negative Cells and Total White Cells in Patients with Chronic Myeloid Leukemia (CML) in Molecular Response.

Thoralf Lange, MD, Thomas Thielsen, Sabine Leiblein, PhD, Ruediger Alt, Guido Zschau, Ralf Burckhardt, Ines Kovacz, Haifa K. Al-Ali, MD, Christina Franke, Rainer Krahl, PhD, Dietger Niederwieser, MD, Michael W. Deininger, MD, PhD

Blood (2005) 106 (11): 1985.

https://doi.org/10.1182/blood.V106.11.1985.1985

Published: 2005

Journal Articles

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Haifa K. Al-Ali, MD, Jeanett Edelmann, MD, Sabine Leiblein, PhD, Christel Mueller, Evelin Hennig, Martina Bless, Christina Franke, Dietger W. Niederwieser, MD

Blood (2005) 106 (11): 3286.

https://doi.org/10.1182/blood.V106.11.3286.3286

Published: 2005

Journal Articles

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma (MM): Preliminary Results of a Phase I Clinical Trial.

Wolfram Poenisch, MD, Marta Rozanski, Sabine Leiblein, PhD, Hartmut Goldschmidt, MD, Almut Wegner, PhD, Dietger Niederwieser, MD

Blood (2004) 104 (11): 4901.

https://doi.org/10.1182/blood.V104.11.4901.4901

Published: 2004

NARROW

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Mobilization of Allogeneic Peripheral Blood Stem Cells in Family Donors with Single-Dose Pegfilgrastim.

Elevated Serum Hepcidin in Patients with AML Prior to and After Allogeneic Hematopoietic Cell Transplantation Does Not Correlate with Transfusional Body Iron, HFE Genotype or Graft Versus Host Disease and May Protect From Excessive Parenchymal Iron Loading.

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Donor CD34+ Cell Chimerism at Day 28 and Chronic Graft-Versus-Host Disease (GvHD) but Not High-Risk Cytogenetics Influence Outcome of Allogeneic Hematopoetic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma after Conventional Chemotherapy: Final Results of a Phase I Study.

Comparable Distribution of Minimal Residual Diesease between CD34 Positive Hematopoietic Progenitors, CD34 Negative Cells and Total White Cells in Patients with Chronic Myeloid Leukemia (CML) in Molecular Response.

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma (MM): Preliminary Results of a Phase I Clinical Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only